Your browser doesn't support javascript.
loading
Development of dermatomyositis after anti-transcriptional intermediary factor 1-γ antibody seroconversion during treatment for small cell lung cancer.
Sato, Yuki; Tanino, Yoshinori; Nikaido, Takefumi; Togawa, Ryuichi; Kawamata, Takaya; Watanabe, Natsumi; Sato, Riko; Yamada, Ryuki; Onuma, Takumi; Tomita, Hikaru; Saito, Mikako; Rikimaru, Mami; Morimoto, Julia; Suzuki, Yasuhito; Minemura, Hiroyuki; Saito, Junpei; Kanazawa, Kenya; Yamada, Syoki; Hashimoto, Yuko; Shibata, Yoko.
Afiliación
  • Sato Y; Department of Pulmonary Medicine, School of Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima, 960-1295, Japan.
  • Tanino Y; Department of Pulmonary Medicine, School of Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima, 960-1295, Japan. ytanino@fmu.ac.jp.
  • Nikaido T; Department of Pulmonary Medicine, School of Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima, 960-1295, Japan.
  • Togawa R; Department of Pulmonary Medicine, School of Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima, 960-1295, Japan.
  • Kawamata T; Department of Pulmonary Medicine, School of Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima, 960-1295, Japan.
  • Watanabe N; Department of Pulmonary Medicine, School of Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima, 960-1295, Japan.
  • Sato R; Department of Pulmonary Medicine, School of Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima, 960-1295, Japan.
  • Yamada R; Department of Pulmonary Medicine, School of Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima, 960-1295, Japan.
  • Onuma T; Department of Pulmonary Medicine, School of Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima, 960-1295, Japan.
  • Tomita H; Department of Pulmonary Medicine, School of Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima, 960-1295, Japan.
  • Saito M; Department of Pulmonary Medicine, School of Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima, 960-1295, Japan.
  • Rikimaru M; Department of Pulmonary Medicine, School of Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima, 960-1295, Japan.
  • Morimoto J; Department of Pulmonary Medicine, School of Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima, 960-1295, Japan.
  • Suzuki Y; Department of Pulmonary Medicine, School of Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima, 960-1295, Japan.
  • Minemura H; Department of Pulmonary Medicine, School of Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima, 960-1295, Japan.
  • Saito J; Department of Pulmonary Medicine, School of Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima, 960-1295, Japan.
  • Kanazawa K; Department of Pulmonary Medicine, School of Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima, 960-1295, Japan.
  • Yamada S; Department of Diagnostic Pathology, School of Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima, 960-1295, Japan.
  • Hashimoto Y; Department of Diagnostic Pathology, School of Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima, 960-1295, Japan.
  • Shibata Y; Department of Pulmonary Medicine, School of Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima, 960-1295, Japan.
BMC Pulm Med ; 22(1): 191, 2022 May 12.
Article en En | MEDLINE | ID: mdl-35549684

Texto completo: 1 Colección: 01-internacional Asunto principal: Dermatomiositis / Carcinoma Pulmonar de Células Pequeñas / Neoplasias Pulmonares / Miositis Límite: Aged / Humans / Male Idioma: En Revista: BMC Pulm Med Año: 2022 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Asunto principal: Dermatomiositis / Carcinoma Pulmonar de Células Pequeñas / Neoplasias Pulmonares / Miositis Límite: Aged / Humans / Male Idioma: En Revista: BMC Pulm Med Año: 2022 Tipo del documento: Article País de afiliación: Japón